We are live on
!
Find out more
LIA
LS Investment Advisors Portfolio holdings
AUM
$738M
1-Year Est. Return
29.35%
This Fund
S&P 500
This Quarter
Est. Return
+4.08%
1 Year Est. Return
+29.35%
3 Year Est. Return
+85.73%
5 Year Est. Return
+98.39%
10 Year Est. Return
+364.74%
AUM
$1.68B
AUM Growth
+$42.6M
(+2.6%)
Cap. Flow
-$12M
Cap. Flow
% of AUM
-0.72%
Top 10 Holdings %
Top 10 Hldgs %
14.19%
Holding
1,908
New
23
Increased
600
Reduced
623
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teradyne
TER
|
+$2.46M |
| 2 |
DuPont de Nemours
DD
|
+$1.89M |
| 3 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$1.32M |
| 4 |
Fidelity National Information Services
FIS
|
+$1.19M |
| 5 |
Hartford Financial Services
HIG
|
+$1.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.98M |
| 2 |
DD
Du Pont De Nemours E I
DD
|
+$1.98M |
| 3 |
Oracle
ORCL
|
+$1.47M |
| 4 |
Cooper Companies
COO
|
+$1.17M |
| 5 |
Automatic Data Processing
ADP
|
+$1.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.45% |
| 2 | Technology | 14.93% |
| 3 | Healthcare | 12.85% |
| 4 | Industrials | 11.29% |
| 5 | Consumer Discretionary | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Boston Scientific
BSX
$68.4B
| $1.19M | 0.07% |
40,621
+2,209
| +6% | +$61K |
|
252
MSCI
MSCI
$41.9B
| $1.18M | 0.07% |
10,090
-284
| -3% | -$31.5K |
|
253
Salesforce
CRM
$148B
| $1.18M | 0.07% |
12,606
+529
| +4% | +$48.7K |
|
254
Baxter International
BAX
$13.8B
| $1.16M | 0.07% |
18,478
-324
| -2% | -$20K |
|
255
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.18B
| $1.16M | 0.07% |
33,325
+1,225
| +4% | +$41.3K |
|
256
Humana
HUM
$44B
| $1.12M | 0.07% |
4,608
+244
| +6% | +$59.8K |
|
257
Harley-Davidson
HOG
$2.59B
| $1.12M | 0.07% |
23,239
+837
| +4% | +$40.7K |
|
258
Marathon Petroleum
MPC
$91.7B
| $1.12M | 0.07% |
19,971
-367
| -2% | -$19.7K |
|
259
Take-Two Interactive
TTWO
$46.3B
| $1.12M | 0.07% |
10,957
+813
| +8% | +$72.8K |
|
260
International Paper
IP
$22.8B
| $1.11M | 0.07% |
20,695
-153
| -0.7% | -$8.04K |
|
261
Domino's
DPZ
$11.7B
| $1.1M | 0.07% |
5,548
+137
| +3% | +$26.7K |
|
262
Broadridge
BR
$17.9B
| $1.08M | 0.06% |
13,336
-254
| -2% | -$19.6K |
|
263
PACCAR
PCAR
$70.4B
| $1.08M | 0.06% |
22,319
-237
| -1% | -$10.7K |
|
264
Public Storage
PSA
$59.3B
| $1.06M | 0.06% |
4,945
-18
| -0.4% | -$3.72K |
|
265
Zoetis
ZTS
$31.9B
| $1.06M | 0.06% |
16,591
+444
| +3% | +$27.8K |
|
266
AutoZone
AZO
$49.1B
| $1.06M | 0.06% |
1,775
+37
| +2% | +$19.7K |
|
|
SCHW
267
Charles Schwab
SCHW
$181B
| $1.05M | 0.06% |
23,988
+804
| +3% | +$33.4K |
|
268
Vertex Pharmaceuticals
VRTX
$122B
| $1.05M | 0.06% |
6,900
-64
| -0.9% | -$9.63K |
|
269
Lam Research
LRCX
$372B
| $1.04M | 0.06% |
56,440
+4,720
| +9% | +$76.6K |
|
270
Intercontinental Exchange
ICE
$88.4B
| $1.04M | 0.06% |
15,087
+605
| +4% | +$39.9K |
|
271
Reinsurance Group of America
RGA
$15.6B
| $1.03M | 0.06% |
7,413
-187
| -2% | -$25.3K |
|
|
ATVI
272
DELISTED
Activision Blizzard
ATVI
| $1.03M | 0.06% |
16,001
+1,088
| +7% | +$67.9K |
|
|
Y
273
DELISTED
Alleghany Corp
Y
| $1.02M | 0.06% |
1,851
+2
| +0.1% | +$1.17K |
|
274
Prologis
PLD
$136B
| $1.02M | 0.06% |
16,125
+647
| +4% | +$39.9K |
|
275
Constellation Brands
STZ
$22.3B
| $1.02M | 0.06% |
5,107
+149
| +3% | +$29.5K |
|
Similar funds
QI
JJBC
CNB
GWS
TWP
CT
SI
HCP
LS Investment Advisors's Q3 2017 Portfolio in Review
As of Q3 2017, LS Investment Advisors held 1,908 positions worth $1.68B, up 2.6% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 2.4%. LS Investment Advisors opened 23 new positions and exited 22, leaving the 1,908-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- LS Investment Advisors's largest Q3 2017 buy was Baker Hughes: 19,387 shares worth $710K.
- LS Investment Advisors added most to Teradyne in Q3 2017, an estimated $2.46M increase.
- LS Investment Advisors's biggest Q3 2017 reduction was AbbVie, cutting an estimated $1.98M.
- LS Investment Advisors fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.98M.
- LS Investment Advisors's ten largest holdings make up 14% of its $1.68B portfolio in Q3 2017.
- LS Investment Advisors opened 23 new positions and closed 22 in Q3 2017.
- LS Investment Advisors's portfolio value rose 2.6% quarter-over-quarter to $1.68B.
Based on LS Investment Advisors's 13F filing for Q3 2017, filed 19 Oct 2017.